Categories IPO, Technology

IPO News: Here’s all you need to know about Enfusion’s upcoming market debut

The company intends to offer around 15.3 million shares at an estimated price between $15 and 17per share

The investment management industry seems to be at an inflection point, with investment strategies becoming increasingly complex and the market demanding greater efficiency and stricter regulatory compliance. It is estimated that global assets under management expanded 40% in the past five years. Enfusion, Inc., a provider of cloud-based investment management solutions, was created with the goal of removing the barriers faced by asset managers.


The Chicago–based company recently revealed plans to offer around 15.3 million shares in an initial public offering at an estimated price between $15 and $17 per share. At the upper end of the price range, the offing is expected to fetch around $260 million. Pursuant to the IPO, the stock will list on the New York Stock Exchange under the ticker symbol ENFN. The company, which was worth $1.5 billion after the last funding round, is expected to reach a valuation of $2 billion after the stock market debut.

Read management/analysts’ comments on quarterly reports

The proceeds from the offering will be used mainly for buying equity interests in the company’s operating subsidiary Enfusion Ltd., repaying debt, and for general corporate purposes. The group of underwriters will be led by Morgan Stanley (NYSE: MS) and Goldman Sachs Group Inc. (NYSE: GS). The management is yet to disclose the IPO date.

SaaS Platform

Enfusion’s software-as-a-solution platform allows investment managers, including hedge funds and family offices, to focus on the primary task of generating returns for their investors. It unifies and simplifies workflows, provides a real-time view of clients’ business, and reduces operational risk through user-defined access controls.

ipo news

Enfusion looks poised to leverage the growing demand for comprehensive investment lifecycle management solutions designed to unify mission-critical systems and combine data for seamless access, in a rapidly changing market. The steady increase in IT spending by investment management firms, which is expected to accelerate in the coming years, and the largely untapped market give enough room for growth.

In Expansion Mode

The company’s growth strategy is focused on broadening and retaining the client base, taking advantage of its leadership position in cloud-native solutions for hedge funds. To meet the growth targets, the company is investing heavily in innovation and expanding to new geographical regions, besides pursuing acquisition of complementary businesses and technologies.

NerdWallet IPO: Should you invest in the personal finance startup?

Since the beginning of the year, the company signed a record 266 new clients, which is seen as a testament to its resilience to the COVID-induced disruption and value of the solutions being offered. In fiscal 2020, Enfusion generated revenues of $79.6 million, which is up 35% from the previous year. At $4.1million, net income was sharply lower than the 2019 level, mainly due to an 85% surge in operating expenses.   


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

Seagate Technology beats Q1 earnings estimate: Infographic

Seagate Technology (NYSE: ALK) reported first-quarter 2022 financial results before the regular market hours on Friday. The company reported Q1 revenue of $3.12 billion, up 35% year-over-year and higher than

Infographic: Schlumberger (SLB) Q3 2021 Earnings Results

Schlumberger Limited (NYSE: SLB) came up with its third-quarter 2021 results on Friday. Revenue increased to $5.8 billion from $5.2 billion last year. Analysts had expected revenue of $5.09 billion.

Honeywell (HON) Q3 2021 Earnings: Key financials and quarterly highlights

Honeywell International Inc. (NASDAQ: HON) reported third quarter 2021 earnings results today. Sales increased 9% year-over-year to $8.4 billion but missed projections of $8.6 billion. On an organic basis, sales

Add Comment
Viewing Highlight